Screening for Hepatocellular Carcinoma Clinical Trial
Official title:
Golgi Protein 73 for Diagnosis of HCC in Egyptian Patients
This case-control study was conducted on 90 patients who were equally divided into two groups. Group 1 included 45 patients with HCV-related chronic liver disease without clinical or radiological evidence of HCC (control group), and Group 2 included 45 patients diagnosed to have HCC by Triphasic abdominal CT (patient group). Serum AFP and GP73 were measured using ELISA technique
n/a